We are live on ! Find out more
SYRA

Syra Health Corp. Class A Common Stock

Delisted

SYRA was delisted on the 17th of April, 2025.

0 hedge funds and large institutions have $0 invested in Syra Health Corp. Class A Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 20 (-2)

100% less capital invested

Capital invested by funds: $18.8K → $0 (-$18.8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
Holders Change
-2
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$16.4K
2
XT
XTX Topco
Cayman Islands
-$2.43K
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
-$16.4K -150,232 Closed
XT
2
XTX Topco
Cayman Islands
-$2.43K -22,301 Closed

SYRA Hedge Fund Activity: Q3 2025 in Review

0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q3 2025, worth a combined $0 — down 100% from $18.8K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SYRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Jane Street, exiting entirely with an estimated $16.4K sold.

  • 0 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q3 2025, down from 2 in Q2 2025.
  • Funds reported $0 of Syra Health Corp. Class A Common Stock stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Syra Health Corp. Class A Common Stock positions in Q3 2025 and 2 closed out, a net change of -2 holders.
  • The largest Syra Health Corp. Class A Common Stock seller in Q3 2025 was Jane Street, an estimated $16.4K sold.

Based on aggregated 13F filings for Q3 2025.